News Archive - Alumni

Iron Buildup in Brain Linked to Higher Risk for Movement Disorders

UC San Diego researchers report that individuals with two copies of a gene mutation show evidence of substantial iron buildup in regions of the brain, raising risk for movement disorders like Parkinson’s disease.

Disparities in United States COVID-19 Vaccine Distribution

Health care facilities in Black metropolitan counties, Hispanic rural counties and hardest-hit counties were less likely to administer COVID-19 vaccines during initial rollout, UC San Diego study finds.

Lactating Mice Pass along Common Antimicrobial to Pups, Initiating Liver Damage

In mouse studies, UC San Diego researchers report that lactating mothers expose their feeding pups to triclosan, an antimicrobial commonly used in consumer products, resulting in early signs of liver damage.

Cash Transfers More Effective than Workforce Training in Improving Lives of Rwandans

In the head-to-head comparison of a workforce-training program and direct cash transfers for Rwandans, cash proves superior in improving economic outcomes of unemployed youths, while training outperforms cash only in the production of business knowledge.

Coronavirus Jumped to Humans at Least Twice at Market in Wuhan, China

In a pair of related studies, UC San Diego researchers show that the origin of the COVID-19 pandemic was at a Chinese market and resulted from at least two instances of the SARS-CoV-2 virus jumping from live animal hosts to humans working or shopping there.

UC San Diego Health Ranks #1 Regionally by U.S. News & World Report

UC San Diego Health top ranked in 10 medical and surgical specialties, among the nation’s best.

A Novel COVID-19 Vaccine Using Modified Bacterial DNA

UC San Diego researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

Post-COVID Lung Disease Shares Origins with Other Scarring Lung Disorders

UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.

Novel Treatment Approach to Alzheimer’s Disease Uses Vitamin B1 Derivative

With a $45 million grant from the NIH, UC San Diego researchers and collaborators will launch a nationwide clinical trial to further investigate the therapeutic potential of benfotiamine, a synthetic version of thiamine (B1), as a treatment for Alzheimer’s disease.

Global Supply Chains Remain Resilient in the Wake of Natural Disasters

While many U.S. policy makers are calling for reshoring and nearshoring to combat trade disruptions caused by COVID-19, new University of California San Diego School of Global Policy and Strategy research suggests retrenchment of global supply chains is unlikely to happen.